Pharma Bribery Inquiry Gets Larger
Written By: Rheingold, Giuffra, Ruffo & Plotkin LLP
Atleast 12 drug and device manufacturers are subject to a federal probe into whether or not they made illegal payments to doctors in foreign countries. While many of the arrangements in question would've been routine had they been done in the United States, since many of the doctors are employed by foreign governments the arrangments might violate the Foreign Corrupt Practices Act. Merck, Eli Lilly, Medtronic, Zimmer, and others all said they are cooperating with federal investigators.
80 percent of drugs approved for sale in 2008 involved clinical trials that were held in foreign countries.
Instances of adverse events for drug not being reported were revealed during a recent trial involving Avandia, a diabetes medication.